Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma

30 Oct 2020

Abstract excerpt

The overall survival of patients with lower grade glioma (LGG) varies greatly, but the current histopathological classification has limitations in predicting patients’ prognosis. Therefore, this study aims to find potential therapeutic target genes and establish a gene signature for predicting the prognosis of LGG. CD44 is a marker of tumor stem cells and has prognostic value in various tumors, but its role in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33381460
DOI: 10.3389/fonc.2020.605737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade GliomaPMID 33381460Read ↗

A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.Semantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

Identification of potential biomarkers related to glioma survival by gene expression profile analysisSemantic proximity Read ↗

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade gliomaSemantic proximity Read ↗

Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment responseSemantic proximity Read ↗

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade GliomasSemantic proximity Read ↗

Screening TCGA database for prognostic genes in lower grade glioma microenvironmentSemantic proximity Read ↗

Identification and Validation of RNA Methylation-Related Related Alternative Splicing Gene Signature for Low Grade Glioma to Predict Survival and Immune LandscapesSemantic proximity Read ↗

Development of a prognostic model of glioma based on immune‑related genesSemantic proximity Read ↗

The Prognostic Value of Risk Score Based on Immunogenenomic Landscape Analysis in GliomaSemantic proximity Read ↗

Prognostic value of anoikis-related genes revealed using multi-omics analysis and machine learning based on lower-grade glioma features and tumour immune microenvironmentSemantic proximity Read ↗

MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.